TABLE 6 RT-PCR, PCR, ISH, and IHC Results in the Control Group
Patient No. | Diagnosis | Tissue | RT-PCR | t(11;14) | ISH | IHCa | |
|---|---|---|---|---|---|---|---|
30 Cycles | 35 Cycles | ||||||
1 | B-CLL | LN | N | N | N | ND | N |
2 | B-CLL | LN | N | P | N | ND | N |
3 | B-CLL | LN | N | N | N | ND | N |
4 | B-CLL | LN | N | P | P | ND | N |
5 | B-CLL | LN | N | N | N | ND | N |
6 | B-CLL | LN | N | N | N | ND | N |
7 | B-CLL | LN | N | N | N | N | N |
8 | MZL | LN | N | N | N | N | N |
9 | MZL | Spleen | N | P | N | N | N |
10 | MZL | Spleen | ND | ND | N | N | N |
11 | MALT | LN | N | N | N | N | N |
12 | MALT | Gastric | P(ni) | P(ni) | N | N | N |
13 | MALT | Gastric | P(ni) | P(ni) | N | N | N |
14 | LBL | LN | N | P | N | N | N |
15 | LBL | LN | N | N | N | ND | N |
16 | LBL | LN | N | N | N | ND | N |
17 | LBL | LN | N | N | N | ND | N |
18 | B-CLL | BMB | ND | ND | ND | N | N |
19 | B-CLL | BMB | ND | ND | ND | N | N |
20 | B-CLL | BMB | ND | ND | ND | N | N |
21 | MZL | BMB | ND | ND | ND | N | N |
22 | MZL | BMB | ND | ND | ND | N | N |
23 | MALT | BMB | ND | ND | ND | N | N |
24 | HCL | BMB | ND | ND | ND | N | N |
25 | HCL | BMB | ND | ND | ND | N | N |
26 | HCL | BMB | ND | ND | ND | N | N |
27 | Normal | BMB | ND | ND | ND | N | N |
28 | Normal | BMB | ND | ND | ND | N | N |
29 | Normal | BMB | ND | ND | ND | N | N |